108 related articles for article (PubMed ID: 20515009)
1. An empirical analysis of health care IPOs and SEOs.
Brau JC; Holloway JM
J Health Care Finance; 2009; 35(4):42-63. PubMed ID: 20515009
[TBL] [Abstract][Full Text] [Related]
2. Aftermarket Performance of Health Care and Biopharmaceutical IPOs: Evidence From ASEAN Countries.
Komenkul K; Kiranand S
Inquiry; 2017 Jan; 54():46958017727105. PubMed ID: 28853306
[TBL] [Abstract][Full Text] [Related]
3. Trends in biopharmaceutical IPOS: 1996-2005.
Williams DR; Young CC
J Health Care Finance; 2006; 33(2):39-54. PubMed ID: 19175239
[TBL] [Abstract][Full Text] [Related]
4. Vulnerability of health to market forces.
Brezis M; Wiist WH
Med Care; 2011 Mar; 49(3):232-9. PubMed ID: 21301368
[TBL] [Abstract][Full Text] [Related]
5. Do governance, equity characteristics, and venture capital nvolvement affect long-term wealth creation in U.S. health care and biotechnology IPOs?
Williams DR; Duncan WJ; Ginter PM; Shewchuk RM
J Health Care Finance; 2006; 33(1):54-71. PubMed ID: 21110493
[TBL] [Abstract][Full Text] [Related]
6. Still golden? More companies eyeing healthcare, but newcomers need to deliver real value.
May D
Mod Healthc; 2011 Jun; 41(26):20. PubMed ID: 21850908
[No Abstract] [Full Text] [Related]
7. The economics of hospital reform: from hierarchical to market-based incentives.
Preker A; Harding A
World Hosp Health Serv; 2003; 39(3):3-10, 42, 44. PubMed ID: 14963886
[TBL] [Abstract][Full Text] [Related]
8. On a smaller scale. Boutique investment firms ready to feed a hungry market.
Kirchheimer B
Mod Healthc; 2001 Jan; 31(2):60, 63. PubMed ID: 11418964
[No Abstract] [Full Text] [Related]
9. Seven guidelines for approaching the new growth mandate.
Goldman EF
Healthc Strateg; 1999 Mar; 3(3):1-6. PubMed ID: 10346555
[No Abstract] [Full Text] [Related]
10. Market orientation in the hospital industry.
Bhuian SN; Abdul-Gader A
Mark Health Serv; 1997; 17(4):36-45. PubMed ID: 10177360
[TBL] [Abstract][Full Text] [Related]
11. An analysis of 1997 healthcare initial public offerings.
Palkon DS
Hosp Top; 1999; 77(3):22-7. PubMed ID: 10787686
[TBL] [Abstract][Full Text] [Related]
12. When the market fails, the poor pay.
Patnaik MM; Stauffer WM; Campagna A; Stauffer CI; Walker PF
Minn Med; 2007 Mar; 90(3):38-40. PubMed ID: 17432756
[No Abstract] [Full Text] [Related]
13. Nursing home performance under case-mix reimbursement: responding to heavy-care incentives and market changes.
Davis MA; Freeman JW; Kirby EC
Health Serv Res; 1998 Oct; 33(4 Pt 1):815-34. PubMed ID: 9776938
[TBL] [Abstract][Full Text] [Related]
14. Hunting for prospects. Despite credit crunch, SPACs still seek investments.
Becker C
Mod Healthc; 2008 Jan; 38(1):30. PubMed ID: 18273970
[No Abstract] [Full Text] [Related]
15. Investor response to health care cost containment legislation: is American health policy designed to fail?
Jacobson CK
Acad Manage J; 1994 Apr; 37(2):440-52. PubMed ID: 10145992
[TBL] [Abstract][Full Text] [Related]
16. HMO behavior and stock market valuation: what does Wall Street reward and punish?
Pauly MV; Hillman AL; Furukawa MF; McCullough JS
J Health Care Finance; 2001; 28(1):7-15. PubMed ID: 11669294
[TBL] [Abstract][Full Text] [Related]
17. Vanguard IPO comes in low.
Galloro V
Mod Healthc; 2011 Jun; 41(26):14. PubMed ID: 21853606
[No Abstract] [Full Text] [Related]
18. 1999 health care IPOs.
Brustad C; Serb C
Hosp Health Netw; 2000 Jan; 74(1):41, 43-6. PubMed ID: 11387747
[No Abstract] [Full Text] [Related]
19. Transitioning health care marketing into the twenty-first century.
Rynne TJ
Mark Health Serv; 1999; 19(2):10-4. PubMed ID: 10557749
[TBL] [Abstract][Full Text] [Related]
20. Resource based view of the firm: measures of reputation among health service-sector businesses.
Smith AD
Health Mark Q; 2008; 25(4):361-82. PubMed ID: 19064477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
